Physiologically based pharmacokinetics of cyclosporine A: extension to tissue distribution kinetics in rats and scale-up to human

scientific article published on 01 November 1998

Physiologically based pharmacokinetics of cyclosporine A: extension to tissue distribution kinetics in rats and scale-up to human is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID9808668

P2093author name stringRowland M
Tanaka C
Kawai R
Mathew D
P433issue2
P921main subjectpharmacokineticsQ323936
cyclosporineQ367700
P304page(s)457-468
P577publication date1998-11-01
P1433published inJournal of Pharmacology and Experimental TherapeuticsQ1500272
P1476titlePhysiologically based pharmacokinetics of cyclosporine A: extension to tissue distribution kinetics in rats and scale-up to human
P478volume287

Reverse relations

cites work (P2860)
Q89482511A Multiscale Physiologically-Based Pharmacokinetic Model for Doxorubicin to Explore its Mechanisms of Cytotoxicity and Cardiotoxicity in Human Physiological Contexts
Q46777776A PBPK workflow for first-in-human dose selection of a subcutaneously administered pegylated peptide
Q36445112A Whole-Body Physiologically Based Pharmacokinetic Model of Gefitinib in Mice and Scale-Up to Humans
Q37470663A mechanistic framework for in vitro-in vivo extrapolation of liver membrane transporters: prediction of drug-drug interaction between rosuvastatin and cyclosporine
Q46769353A physiological model to evaluate drug kinetics in patients with hemorrhagic shock followed by fluid resuscitation. Application to amoxicillin-clavulanate
Q35888381A physiologically based pharmacokinetic model of mitoxantrone in mice and scale-up to humans: a semi-mechanistic model incorporating DNA and protein binding
Q50722759A semi-physiological population pharmacokinetic model describing the non-linear disposition of indisulam.
Q43840428A stochastic model describes the heterogeneous pharmacokinetics of cyclosporin
Q31017890Analyzing multi-response data using forcing functions
Q51761715Comparison of the influence of cyclosporine and tacrolimus on the pharmacokinetics of prednisolone in adult male kidney transplant recipients.
Q33383176Covariate-based dose individualization of the cytotoxic drug indisulam to reduce the risk of severe myelosuppression
Q43767845Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: application of PBPK modeling in the assessment of drug-drug interaction potential
Q43663687Development of a physiologically based model for oseltamivir and simulation of pharmacokinetics in neonates and infants
Q34749073Distribution of cyclosporin in organ transplant recipients
Q37246076Dose adjustment strategy of cyclosporine A in renal transplant patients: evaluation of anthropometric parameters for dose adjustment and C0 vs. C2 monitoring in Japan, 2001-2010.
Q28473451Drug-class specific impact of antivirals on the reproductive capacity of HIV
Q36693701Effect of Ritonavir on (99m)Technetium-Mebrofenin Disposition in Humans: A Semi-PBPK Modeling and In Vitro Approach to Predict Transporter-Mediated DDIs
Q42185186Human structural proteome-wide characterization of Cyclosporine A targets
Q27022933ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans
Q40905288Incorporation of stochastic variability in mechanistic population pharmacokinetic models: handling the physiological constraints using normal transformations
Q42919793Influence of Dosing Schedule on Organ Exposure to Cyclosporin in Pediatric Hematopoietic Stem Cell Transplantation: Analysis with a PBPK Model
Q39192461Interpreting copper bioaccumulation dynamics in tilapia using systems-level explorations of pulsed acute/chronic exposures
Q37504548Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver
Q51919468Mechanistic approaches to volume of distribution predictions: understanding the processes.
Q82100906Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat
Q50698909Physiologically based pharmacokinetic (PBPK) modeling of everolimus (RAD001) in rats involving non-linear tissue uptake.
Q41368460Physiologically based pharmacokinetic model for 6-mercpatopurine: exploring the role of genetic polymorphism in TPMT enzyme activity
Q50476254Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexate
Q51905139Physiologically based pharmacokinetic modelling: a sub-compartmentalized model of tissue distribution.
Q49091990Physiologically based pharmacokinetics of cyclosporine A: reevaluation of dose-nonlinear kinetics in rats
Q37619315Physiologically-based PK/PD modelling of therapeutic macromolecules
Q88404781Physiologically-based modeling and interspecies prediction of paclitaxel pharmacokinetics
Q37820451Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion.
Q36204764Physiologically-based pharmacokinetic modeling of target-mediated drug disposition of bortezomib in mice
Q37802266Prediction of Exposure–Response Relationships to Support First-in-Human Study Design
Q42129809Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats
Q30327851The role of population pharmacokinetics in drug development in light of the Food and Drug Administration's 'Guidance for Industry: population pharmacokinetics'.
Q57295021The use of PBPK modeling across the pediatric age range using propofol as a case
Q89982792Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids
Q42739574Use of dried blood spots in drug development: pharmacokinetic considerations
Q42242976Use of partition coefficients in flow-limited physiologically-based pharmacokinetic modeling
Q35186644Whole body pharmacokinetic models

Search more.